Analyst Price Targets — ZBH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 8:25 pm | — | BMO Capital | $95.00 | $87.56 | TheFly | Zimmer Biomet initiated with a Market Perform at BMO Capital |
| April 29, 2026 1:52 pm | — | Truist Financial | $92.00 | $80.80 | TheFly | Zimmer Biomet price target lowered to $92 from $98 at Truist |
| April 29, 2026 11:31 am | — | Canaccord Genuity | $83.00 | $82.80 | TheFly | Zimmer Biomet price target lowered to $83 from $93 at Canaccord |
| April 29, 2026 11:21 am | Rick Wise | Stifel Nicolaus | $105.00 | $82.80 | TheFly | Zimmer Biomet price target lowered to $105 from $110 at Stifel |
| April 29, 2026 11:00 am | — | Robert W. Baird | $92.00 | $82.80 | TheFly | Zimmer Biomet price target lowered to $92 from $100 at Baird |
| April 29, 2026 9:45 am | Matt Miksic | Barclays | $94.00 | $82.80 | TheFly | Zimmer Biomet price target lowered to $94 from $100 at Barclays |
| February 12, 2026 1:04 pm | Matt Miksic | Barclays | $100.00 | $96.69 | TheFly | Zimmer Biomet price target lowered to $100 from $104 at Barclays |
| February 11, 2026 2:08 pm | — | UBS | $89.00 | $93.69 | TheFly | Zimmer Biomet price target raised to $89 from $86 at UBS |
| January 28, 2026 1:09 pm | — | UBS | $86.00 | $85.27 | TheFly | Zimmer Biomet price target lowered to $86 from $88 at UBS |
| January 9, 2026 11:51 am | — | Bernstein | $99.00 | $94.08 | TheFly | Zimmer Biomet price target raised to $99 from $97 at Bernstein |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ZBH

WARSAW, Ind., July 14, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chintan Desai has been named president of the company's Asia Pacific Region, effective immediately.

WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m.

Zimmer Biomet ZBH appears well positioned for growth in the coming quarters, supported by the continued execution of its market strategies centered on People and Culture, Operational Excellence, and Innovation and Diversification pillars. Growth in the knee business revenues is backed by the robust adoption of its cementless offerings.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Medical device maker Zimmer Biomet plans to hire 500 employees over the next three years for its newly opened technology centre in Bengaluru, a senior executive said, as the U.S.-listed company expands its presence in India.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
